![](/img/cover-not-exists.png)
First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti–IL-20 Monoclonal Antibody in Patients with Psoriasis
Gottlieb, Alice B., Krueger, James G., Sandberg Lundblad, Mia, Göthberg, Marie, Skolnick, Brett E., Nishikawa, HiroyoshiVolume:
10
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0134703
Date:
August, 2015
File:
PDF, 2.52 MB
english, 2015